Literature DB >> 28508329

Long Non-Coding RNA SNHG6 as a Potential Biomarker for Hepatocellular Carcinoma.

Maryam Tahmasebi Birgani1, Mohammadreza Hajjari2, Arman Shahrisa3, Atefeh Khoshnevisan4, Zahra Shoja5, Paria Motahari6, Baharak Farhangi7.   

Abstract

Long Non-coding RNAs (lncRNAs) refer to all non-protein coding transcripts longer than 200 nucleotides. Their critical roles in different biological pathways have been already well established. Altered expression of lncRNAs can be involved in the cancer initiation and/or progression. Since patients with hepatocellular carcinoma (HCC) are usually diagnosed in late stages, developing diagnostic methods seems to be essential. In this study, the expression levels of different lncRNAs were systematically analysed in different genomic and transcriptome datasets. The analyses showed that SNHG6 is among the lncRNAs with distinctive dysregulation of expression and copy number variation in HCC tumors compared with normal tissues. The results also suggest that the dysregulation of SNHG6 is highly cancer type specific. Through co-occurrence analyses, we found that SNHG6 and its related co-expressed genes on 8q are involved in the structural integrity of ribosome and translation. This comprehensive in silico analysis, provides a resource for investigating SNHG6 in hepatocellular carcinoma and lays the groundwork for design of next researches.

Entities:  

Keywords:  Biomarker; Hepatocellular carcinoma; Long noncoding RNA; SNHG6; Systematic analysis

Mesh:

Substances:

Year:  2017        PMID: 28508329     DOI: 10.1007/s12253-017-0241-3

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  30 in total

1.  Characterization of genomic alterations in hepatoblastomas. A role for gains on chromosomes 8q and 20 as predictors of poor outcome.

Authors:  R G Weber; T Pietsch; D von Schweinitz; P Lichter
Journal:  Am J Pathol       Date:  2000-08       Impact factor: 4.307

2.  RPL39L is an example of a recently evolved ribosomal protein paralog that shows highly specific tissue expression patterns and is upregulated in ESCs and HCC tumors.

Authors:  Queenie Wing-Lei Wong; Jia Li; Sheng Rong Ng; Seng Gee Lim; Henry Yang; Leah A Vardy
Journal:  RNA Biol       Date:  2013-12-20       Impact factor: 4.652

3.  Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma.

Authors:  Elisa Wurmbach; Ying-bei Chen; Greg Khitrov; Weijia Zhang; Sasan Roayaie; Myron Schwartz; Isabel Fiel; Swan Thung; Vincenzo Mazzaferro; Jordi Bruix; Erwin Bottinger; Scott Friedman; Samuel Waxman; Josep M Llovet
Journal:  Hepatology       Date:  2007-04       Impact factor: 17.425

4.  The UCSC Cancer Genomics Browser.

Authors:  Jingchun Zhu; J Zachary Sanborn; Stephen Benz; Christopher Szeto; Fan Hsu; Robert M Kuhn; Donna Karolchik; John Archie; Marc E Lenburg; Laura J Esserman; W James Kent; David Haussler; Ting Wang
Journal:  Nat Methods       Date:  2009-04       Impact factor: 28.547

5.  The UCSC Cancer Genomics Browser: update 2011.

Authors:  J Zachary Sanborn; Stephen C Benz; Brian Craft; Christopher Szeto; Kord M Kober; Laurence Meyer; Charles J Vaske; Mary Goldman; Kayla E Smith; Robert M Kuhn; Donna Karolchik; W James Kent; Joshua M Stuart; David Haussler; Jingchun Zhu
Journal:  Nucleic Acids Res       Date:  2010-11-08       Impact factor: 16.971

6.  Potential long non-coding RNAs to be considered as biomarkers or therapeutic targets in gastric cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan
Journal:  Front Genet       Date:  2013-10-18       Impact factor: 4.599

7.  Expression Atlas update--an integrated database of gene and protein expression in humans, animals and plants.

Authors:  Robert Petryszak; Maria Keays; Y Amy Tang; Nuno A Fonseca; Elisabet Barrera; Tony Burdett; Anja Füllgrabe; Alfonso Muñoz-Pomer Fuentes; Simon Jupp; Satu Koskinen; Oliver Mannion; Laura Huerta; Karine Megy; Catherine Snow; Eleanor Williams; Mitra Barzine; Emma Hastings; Hendrik Weisser; James Wright; Pankaj Jaiswal; Wolfgang Huber; Jyoti Choudhary; Helen E Parkinson; Alvis Brazma
Journal:  Nucleic Acids Res       Date:  2015-10-19       Impact factor: 16.971

8.  The UCSC Cancer Genomics Browser: update 2013.

Authors:  Mary Goldman; Brian Craft; Teresa Swatloski; Kyle Ellrott; Melissa Cline; Mark Diekhans; Singer Ma; Chris Wilks; Josh Stuart; David Haussler; Jingchun Zhu
Journal:  Nucleic Acids Res       Date:  2012-10-29       Impact factor: 16.971

9.  Expression Atlas update--a database of gene and transcript expression from microarray- and sequencing-based functional genomics experiments.

Authors:  Robert Petryszak; Tony Burdett; Benedetto Fiorelli; Nuno A Fonseca; Mar Gonzalez-Porta; Emma Hastings; Wolfgang Huber; Simon Jupp; Maria Keays; Nataliya Kryvych; Julie McMurry; John C Marioni; James Malone; Karine Megy; Gabriella Rustici; Amy Y Tang; Jan Taubert; Eleanor Williams; Oliver Mannion; Helen E Parkinson; Alvis Brazma
Journal:  Nucleic Acids Res       Date:  2013-12-04       Impact factor: 16.971

10.  Human colorectal cancer-specific CCAT1-L lncRNA regulates long-range chromatin interactions at the MYC locus.

Authors:  Jian-Feng Xiang; Qing-Fei Yin; Tian Chen; Yang Zhang; Xiao-Ou Zhang; Zheng Wu; Shaofeng Zhang; Hai-Bin Wang; Junhui Ge; Xuhua Lu; Li Yang; Ling-Ling Chen
Journal:  Cell Res       Date:  2014-03-25       Impact factor: 25.617

View more
  17 in total

1.  Long Noncoding RNAs in Colorectal Adenocarcinoma; an in silico Analysis.

Authors:  Hossein Ansari; Arman Shahrisa; Yaser Tahmasebi Birgani; Maryam Tahmasebi Birgani; Mohammadreza Hajjari; Javad Mohammadi Asl
Journal:  Pathol Oncol Res       Date:  2018-06-13       Impact factor: 3.201

2.  Up-regulation of SNHG6 activates SERPINH1 expression by competitive binding to miR-139-5p to promote hepatocellular carcinoma progression.

Authors:  Gang Wu; Xueming Ju; Youyu Wang; Zhixi Li; Xianfeng Gan
Journal:  Cell Cycle       Date:  2019-07-01       Impact factor: 4.534

3.  LncRNA SNHG6 promotes G1/S-phase transition in hepatocellular carcinoma by impairing miR-204-5p-mediated inhibition of E2F1.

Authors:  Kai Chen; Yifu Hou; Rui Liao; Youzan Li; Hongji Yang; Jun Gong
Journal:  Oncogene       Date:  2021-04-06       Impact factor: 9.867

4.  A long non-coding RNA expression signature to predict survival of patients with colon adenocarcinoma.

Authors:  Weinan Xue; Jingwen Li; Fan Wang; Peng Han; Yanlong Liu; Binbin Cui
Journal:  Oncotarget       Date:  2017-09-19

Review 5.  Behind the curtain of non-coding RNAs; long non-coding RNAs regulating hepatocarcinogenesis.

Authors:  Aya El Khodiry; Menna Afify; Hend M El Tayebi
Journal:  World J Gastroenterol       Date:  2018-02-07       Impact factor: 5.742

Review 6.  The Role of Long Non-Coding RNAs in Hepatocarcinogenesis.

Authors:  Manuela Lanzafame; Gaia Bianco; Luigi M Terracciano; Charlotte K Y Ng; Salvatore Piscuoglio
Journal:  Int J Mol Sci       Date:  2018-02-28       Impact factor: 5.923

Review 7.  MicroRNAs in Rectal Cancer: Functional Significance and Promising Therapeutic Value.

Authors:  Laura Imedio; Ion Cristóbal; Jaime Rubio; Andrea Santos; Federico Rojo; Jesús García-Foncillas
Journal:  Cancers (Basel)       Date:  2020-07-24       Impact factor: 6.639

8.  SNHG 6 promotes the progression of Colon and Rectal adenocarcinoma via miR-101-3p and Wnt/β-catenin signaling pathway.

Authors:  Qianwen Shao; Jing Xu; Rong Deng; Wei Wei; Bing Zhou; Chao Yue; Miaoling Zhu; Haitao Zhu
Journal:  BMC Gastroenterol       Date:  2019-09-18       Impact factor: 3.067

9.  Knockdown of LINC00504 Inhibits the Proliferation and Invasion of Breast Cancer via the Downregulation of miR-140-5p.

Authors:  Tieying Hou; Long Ye; Shulin Wu
Journal:  Onco Targets Ther       Date:  2021-07-02       Impact factor: 4.147

10.  The targeted inhibition of prostate cancer by iron-based nanoparticles based on bioinformatics.

Authors:  Feng Xiao; Jiayu Liu; Yongbo Zheng; Zhen Quan; Wei Sun; Yao Fan; Chunli Luo; Hailiang Li; Xiaohou Wu
Journal:  J Biomater Appl       Date:  2020-12-06       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.